Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

American Heart Journal

Volumn 162, Issue 4, 2011, Pages

  McMurray, John J V ^a,b   Uno, Hajime ^c   Jarolim, Petr ^b   Desai, Akshay S ^b   De Zeeuw, Dick ^d   Eckardt, Kai Uwe ^e   Ivanovich, Peter ^f   Levey, Andrew S ^g   Lewis, Eldrin F ^b   McGill, Janet B ^h   Parfrey, Patrick ⁱ   Parving, Hans Henrik ^j   Toto, Robert M ^k   Solomon, Scott D ^b   Pfeffer, Marc A ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f NORTHWESTERN UNIVERSITY   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Health Sciences Centre St John's   (Canada)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k UNIVERSITY OF TEXAS AT DALLAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ORAL ANTIDIABETIC AGENT; SULFONAMIDE; TROPONIN T;

AGED; ANEMIA; ANGINA PECTORIS; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ECG ABNORMALITY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 80053634010     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.07.016     Document Type: Article

References (15)

1. S. van der Zee, U. Baber, and S. Elmariah Cardiovascular risk factors in patients with chronic kidney disease Nat Rev Cardiol 6 2009 580 589
2. P.T. Vlagopoulos, H. Tighiouart, and D.E. Weiner Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease J Am Soc Nephrol 16 2005 3403 3410 (Pubitemid 46179344)
3. G. Zoppini, G. Targher, and M. Chonchol Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients Atherosclerosis 210 2010 575 580
4. M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen TREAT Investigators. A trial of darbepoetinalfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 2019 2032
5. M.J. Pencina, R.B. D'Agostino, and M.J. Pencina Extensions of netreclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
6. T. Ninomiya, V. Perkovic, and B.E. de Galan Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes J Am Soc Nephrol 20 2009 1813 1821
7. H. Haller, J. Menne, and G. Mancia Awareness and behaviour of European physicians in relation to microalbuminuria and organ damage: an ESH-endorsed survey J Hypertens 28 2010 2204 2209
8. Chronic Kidney Disease Prognosis Consortium, K. Matsushita, and M. van der Velde Association of estimated glomerular filtration rate and albuminuria with all-cause andcardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
9. N.S. Anavekar, D.J. Gans, and T. Berl Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria Kidney Int Suppl 92 2004 S50 S55
10. K. Thygesen, J. Mair, and H. Katus Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.Recommendations for the use of cardiac troponin measurement in acute cardiac care Eur Heart J 31 2010 2197 2204
11. N.A. Abbas, R.I. John, and M.C. Webb Cardiac troponins and renal function in nondialysis patients with chronic kidney disease Clin Chem 51 2005 2059 2066 (Pubitemid 41532621)
12. C. Ronco Cardiorenal syndromes: definition and classification Contrib Nephrol 164 2010 33 38
13. M. Sakuma, M. Nakamura, and F. Tanaka Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population Circ J 74 2010 792 797
14. W.J. Austin, V. Bhalla, and I. Hernandez-Arce Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease Am J Clin Pathol 126 2006 506 512 (Pubitemid 44498499)
15. H.H. Parving, B.M. Brenner, and J.J. McMurray Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design Nephrol Dial Transplant 24 2009 1663 1671